Antonio Moreno

1.9k total citations
34 papers, 427 citations indexed

About

Antonio Moreno is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antonio Moreno has authored 34 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antonio Moreno's work include Sepsis Diagnosis and Treatment (8 papers), Pneumonia and Respiratory Infections (7 papers) and Retinal Diseases and Treatments (5 papers). Antonio Moreno is often cited by papers focused on Sepsis Diagnosis and Treatment (8 papers), Pneumonia and Respiratory Infections (7 papers) and Retinal Diseases and Treatments (5 papers). Antonio Moreno collaborates with scholars based in Spain, United States and Colombia. Antonio Moreno's co-authors include Alejandro Rodríguez, Felipe Sánchez de la Cuesta, J.P. De La Cruz, María Bodi, Raquel Carbonell, Ignacio Martín‐Loeches, Josep Gómez, Juan Guardiola, Sandra Trefler and Jordi Solé‐Violán and has published in prestigious journals such as European Journal of Pharmacology, Intensive Care Medicine and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Antonio Moreno

32 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Moreno Spain 13 174 100 96 81 57 34 427
Hamidreza Reihani Iran 13 113 0.6× 51 0.5× 52 0.5× 35 0.4× 61 1.1× 42 491
Yasumitsu Mizobata Japan 13 139 0.8× 28 0.3× 71 0.7× 88 1.1× 164 2.9× 60 469
Simone Bastrup Israelsen Denmark 14 114 0.7× 170 1.7× 30 0.3× 37 0.5× 51 0.9× 31 452
Clara Arango Colombia 8 378 2.2× 79 0.8× 68 0.7× 86 1.1× 95 1.7× 13 705
Patrik Gille-Johnson Sweden 12 120 0.7× 171 1.7× 32 0.3× 46 0.6× 20 0.4× 21 404
Daniel Modin Denmark 17 326 1.9× 199 2.0× 92 1.0× 17 0.2× 111 1.9× 90 1.0k
Gowtham Rao United States 11 112 0.6× 124 1.2× 33 0.3× 25 0.3× 65 1.1× 25 455
Yoann Zerbib France 10 105 0.6× 48 0.5× 74 0.8× 55 0.7× 34 0.6× 32 313
Arda Kiani Iran 15 100 0.6× 155 1.6× 282 2.9× 28 0.3× 97 1.7× 96 754
Mary‐Nicoleta Lupu Romania 5 201 1.2× 25 0.3× 31 0.3× 82 1.0× 55 1.0× 6 363

Countries citing papers authored by Antonio Moreno

Since Specialization
Citations

This map shows the geographic impact of Antonio Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Moreno more than expected).

Fields of papers citing papers by Antonio Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Moreno. The network helps show where Antonio Moreno may publish in the future.

Co-authorship network of co-authors of Antonio Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Moreno. A scholar is included among the top collaborators of Antonio Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Moreno. Antonio Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Moreno, Antonio, Raquel Carbonell, Emili Dı́az, et al.. (2023). Effectiveness of prolonged versus standard‐course of oseltamivir in critically ill patients with severe influenza infection: A multicentre cohort study. Journal of Medical Virology. 95(8). e29010–e29010. 3 indexed citations
3.
Claverías, Laura, Mònica Magret, Joan Ramón Masclans, et al.. (2023). Timing of intubation and ICU mortality in COVID-19 patients: a retrospective analysis of 4198 critically ill patients during the first and second waves. BMC Anesthesiology. 23(1). 140–140. 10 indexed citations
4.
Carbonell, Raquel, Antonio Moreno, Ignacio Martín‐Loeches, María Bodi, & Alejandro Rodríguez. (2023). The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in Adults. Antibiotics. 12(1). 161–161. 14 indexed citations
5.
Rodríguez, Alejandro, et al.. (2022). Antibiotics in development for multiresistant gram-negative bacilli. Medicina Intensiva (English Edition). 46(11). 630–640. 1 indexed citations
6.
Reyes, Luis Felipe, Ignacio Martín‐Loeches, Emili Dı́az, et al.. (2022). Prior influenza vaccine is not a risk factor for bacterial coinfection in patients admitted to the ICU due to severe influenza. Medicina Intensiva (English Edition). 46(8). 436–445. 2 indexed citations
7.
Carbonell, Raquel, Antonio Moreno, Ignacio Martín‐Loeches, et al.. (2021). Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia. Antibiotics. 10(4). 350–350. 12 indexed citations
8.
Gärtner, Silvia, Paula Fernández‐Álvarez, Isabel Vieira de Assis Lima, et al.. (2021). Inflammation in cystic fibrosis patients: study of the eicosanoid pathway and severity correlations. PA2106–PA2106. 2 indexed citations
9.
Moreno, Antonio, Alejandro Rodríguez, Jordi Solé‐Violán, et al.. (2021). Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia. ERJ Open Research. 7(1). 888–2020. 17 indexed citations
10.
Reyes, Luis Felipe, Ignacio Martín‐Loeches, Emili Dı́az, et al.. (2021). Prior influenza vaccine is not a risk factor for bacterial coinfection in patients admitted to the ICU due to severe influenza. Medicina Intensiva. 46(8). 436–445.
11.
Moreno, Antonio, Raquel Carbonell, María Bodi, & Alejandro Rodríguez. (2020). Revisión sistemática sobre la utilidad pronóstica del dímero-D, coagulación intravascular diseminada y tratamiento anticoagulante en pacientes graves con COVID-19. Medicina Intensiva. 45(1). 42–55. 13 indexed citations
12.
Chico‐Fernández, Mario, Jesús Abelardo Barea‐Mendoza, Antonio Moreno, et al.. (2020). Associated risk factors and outcomes of acute kidney injury in severe trauma: Results from the Spanish trauma ICU registry (RETRAUCI). Anaesthesia Critical Care & Pain Medicine. 39(4). 503–506. 7 indexed citations
13.
Moreno, Antonio, Alejandro Rodríguez, Luis Felipe Reyes, et al.. (2018). Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intensive Care Medicine. 44(9). 1470–1482. 101 indexed citations
14.
Sirgo, Gonzalo, Josep Gómez, Antonio Moreno, et al.. (2018). Validation of the ICU-DaMa tool for automatically extracting variables for minimum dataset and quality indicators: The importance of data quality assessment. International Journal of Medical Informatics. 112. 166–172. 21 indexed citations
15.
Ríos, Antonio, L. Martínez‐Alarcón, Marco Antonio Ayala‐García, et al.. (2010). Level of Acceptance of a Clinical Solid Organ Xenotransplantation Program Among Personnel in Organ Transplant-Related Services in Spanish, Mexican, and Cuban Hospital Centers. Transplantation Proceedings. 42(1). 222–227. 13 indexed citations
16.
Moreno, Antonio, et al.. (2010). PCV31 BLOOD PRESSURE CONTROL AND ANTIHYPERTENSIVE STRATEGY DIFFERENCES ACCORDING TO PATIENTS AGE. Value in Health. 13(7). A346–A346. 1 indexed citations
17.
Correa, José Antonio González, M.M. Arrebola, Javier Muñoz-Marín, et al.. (2007). Gender differences in the effect of aspirin on retinal ischemia, prostanoid synthesis and nitric oxide production in experimental type 1-like diabetes. Vascular Pharmacology. 47(2-3). 83–89. 6 indexed citations
18.
Cruz, J.P. De La, et al.. (2002). Nitric Oxide-cGMP and Prostacyclin-cAMP Pathways in Patients with Type II Diabetes and Different Types of Retinopathy. Pathophysiology of Haemostasis and Thrombosis. 32(1). 25–32. 8 indexed citations
19.
Cruz, J.P. De La, et al.. (1998). Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes. European Journal of Pharmacology. 350(1). 81–85. 16 indexed citations
20.
Cruz, J.P. De La, et al.. (1998). Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats. European Journal of Pharmacology. 360(1). 37–42. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hamidreza Reihani Breakdown of academic impact, for papers by Yasumitsu Mizobata Breakdown of academic impact, for papers by Simone Bastrup Israelsen Breakdown of academic impact, for papers by Clara Arango Breakdown of academic impact, for papers by Patrik Gille-Johnson Breakdown of academic impact, for papers by Daniel Modin Breakdown of academic impact, for papers by Gowtham Rao Breakdown of academic impact, for papers by Yoann Zerbib Breakdown of academic impact, for papers by Arda Kiani Breakdown of academic impact, for papers by Mary‐Nicoleta Lupu
Rankless by CCL
2026